Tag: Trace Pharmaceuticals

Introduction As municipal and industrial treatment plants face increasingly stringent regulatory limits for PFAS, microplastics, heavy metals, and trace pharmaceuticals, engineers are discovering the limitations of conventional polymeric membranes and granular activated carbon (GAC). To achieve higher permselectivity while reducing the severe energy penalties of high-pressure reverse osmosis (RO), plant designers must look to the […]

Introduction In modern municipal and industrial infrastructure, conventional granular media filtration is increasingly falling short of tightening regulatory discharge limits and complex feed water profiles. As facilities face emerging contaminants like PFAS, microplastics, and trace pharmaceuticals, coupled with a push toward direct potable reuse (DPR) and zero liquid discharge (ZLD), engineers are pivoting to Advanced […]